Protocol · Cancer Support
Myelodysplastic Syndrome (MDS) Supportive Care Protocol
Vitamin D and Omega-3 Fatty Acids are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Myelodysplastic Syndrome (MDS) Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Vitamin D | Amount listed: 2,000–4,000 IU daily (monitor levels; target 40–60 ng/mL) | Supports immune function; deficiency common in MDS and associated with worse outcomes | Not graded yet | |
| Omega-3 Fatty Acids | Amount listed: 2–3 g EPA+DHA daily | Anti-inflammatory effects; may support bone marrow function and reduce transfusion needs | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Vitamin B12 | Amount listed: 1,000 mcg daily (check levels first) | Essential for red blood cell production; deficiency can worsen anemia | Not graded yet | |
| Folate | Amount listed: 400–800 mcg daily (as methylfolate; check levels first) | Supports red blood cell production; deficiency should be corrected | Not graded yet | |
| Green Tea Extract (EGCG) | Amount listed: 400–800 mg EGCG daily | Polyphenols may have anti-leukemic properties; studied for MDS progression | Not graded yet | |
| Curcumin | Amount listed: 500–1,000 mg daily (with piperine for absorption) | Anti-inflammatory and may have effects on hematopoietic cells | Not graded yet | |
| Coenzyme Q10 | Amount listed: 100–200 mg daily | Supports mitochondrial function and may help with fatigue | Not graded yet | |
| Probiotics | Amount listed: 20–50 billion CFU daily | Support gut health and immune function; may help with treatment side effects | Not graded yet | |
How this protocol works
In plain language
Myelodysplastic syndromes (MDS) are a group of bone marrow disorders where the bone marrow doesn't produce enough healthy blood cells. The bone marrow produces abnormal (dysplastic) cells that don't function properly, leading to low blood counts: anemia (low red cells causing fatigue), neutropenia (low white cells increasing infection risk), and thrombocytopenia (low platelets causing bleeding risk). MDS primarily affects older adults (median age 70) and can range from slow-progressing to aggressive forms that may transform into acute myeloid leukemia (AML).
CRITICAL: MDS requires management by a hematologist/oncologist. Treatment depends on the MDS subtype, risk category (IPSS/IPSS-R scoring), cytopenias, and patient factors. Options include: supportive care (transfusions, growth factors), disease-modifying drugs (azacitidine, decitabine, lenalidomide for del(5q)), and potentially stem cell transplant for eligible higher-risk patients. Iron overload from repeated transfusions requires monitoring and possible chelation therapy. These supplements support overall health but do NOT treat MDS. Always discuss supplements with your oncology team before taking them.
Vitamin D* deficiency is very common in MDS patients and associated with worse outcomes. Maintaining optimal levels supports immune function.
Omega-3 Fatty Acids* have anti-inflammatory effects and may support bone marrow function.
Vitamin B12 and Folate* are essential for red blood cell production. Deficiencies should be identified and corrected, though supplementation doesn't treat the underlying MDS.
Green Tea Extract (EGCG)* has been studied in a pilot trial for MDS with some interest in its effects on disease progression.
Curcumin* has anti-inflammatory properties and is being studied for various hematologic conditions.
Coenzyme Q10* may help with the significant fatigue that affects most MDS patients.
Probiotics* support gut health and immune function.
Expected timeline: These supplements provide supportive care. MDS treatment and monitoring are ongoing, often for years. Transfusion requirements, blood counts, and disease progression are monitored regularly.